ecrin-mdr-crcClinical2014carcinoma del colon-retto inoperabile e metastaticoUnresectable and metastatic colorectal cancerMetastatic colorectal cancerMetastatic Colorectal CancerCarcinoma Del Colon-retto Inoperabile E MetastaticoUnresectable And Metastatic Colorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2532389Italy3CAMPTOFLUOROURACILE TEVAXELODALEVOFOLENEOXALIPLATINOAvastinECRIN MDROngoingfalseStudy evaluating, as first-line treatment of metastatic colorectal cancer, Bevacizumab +FOLFIRI followed by Bevacizumab + FOLFOX( or XELOX) or the reverse sequence Bevacizumab + FOLFOX (or XELOX) folloewed by Bevacizumab + FOLFIRI versus the standard Bevacizumab+ FOLFIRIPrimary objectives: Progression free survival2014-03-1525323892013-003244-23